B-cell–specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion

Key Points IRF4 deletion in Tcl-1 tg mice and IRF4low CLL patients enhances disease progression due to increased tumor immune evasion. This is caused by a downregulation of the antigen processing and presentation machinery and reduced T-cell costimulation.